The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma

Dedifferentiated liposarcomas (DDLPS) are highly resistant to conventional chemo- and radiotherapies, with surgical resection remaining the classic treatment strategy; therefore there is a pressing need for novel anti-DDLPS targeted chemotherapeutics. Hepatocyte growth factor receptor (Met) expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bill, Kate Lynn J., Garnett, Jeannine, Ma, Xiaoyan, May, Caitlin, Bolshakov, Svetlana, Lazar, Alexander J., Lev, Dina, Pollock, Raphael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520775/
https://www.ncbi.nlm.nih.gov/pubmed/26006023
http://dx.doi.org/10.1038/labinvest.2015.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520775/
https://www.ncbi.nlm.nih.gov/pubmed/26006023
http://dx.doi.org/10.1038/labinvest.2015.62

Ejemplares similares